Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NANOFER-THE-0504: A Trial to Assess the Safety and Tolerability of an Investigational Drug THE-0504 for Patients With Solid Tumors

NCT07646106 is registered in ClinicalTrials.gov with Thena Biotech S.r.l. as lead sponsor.

NCT NCT07646106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07646106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NANOFER-THE-0504: A Trial to Assess the Safety and Tolerability of an Investigational Drug THE-0504 for Patients With Solid Tumors
Lead sponsor
Thena Biotech S.r.l.
Phase
Phase 1
Overall status
Recruiting
Start date
November 13, 2024
Completion date
May 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal carcinoma (crc), gastric cancer (gc), pancreas adenocarcinoma, small cell lung cancer (sclc), triple -negative breast cancer